Thompson David E. 4
4 · Anthera Pharmaceuticals Inc · Filed May 20, 2013
Insider Transaction Report
Form 4
Thompson David E.
Director
Transactions
- Award
Stock Option (right to buy)
2013-05-17+100,000→ 100,000 totalExercise: $0.61Exp: 2023-05-16→ Common Stock (100,000 underlying)
Footnotes (1)
- [F1]The stock option vests and becomes exercisable in 12 equal monthly installments from the grant date of May 17, 2013. This stock option is fully exercisable on May 17, 2014.